Subarachnoid Haemorrhage
8
1
1
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
13%
1 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (8)
Levosimendan as Treatment of Aneurysmal SubArachnoid Haemorrhage
Ethnicity and Onset of Cardiovascular Disease: A CALIBER Study
Understanding the Role of Autoimmune Disorders on the Initial Presentation of Cardiovascular Disease
Mechanical Ventilation in Brain-injured Patients
Simvastatin in Aneurysmal Subarachnoid Haemorrhage (STASH) a Multicentre Randomised Controlled Clinical Trial
Heart Rate and Initial Presentation of Cardiovascular Diseases (Caliber)
Social Deprivation and Initial Presentation of 12 Cardiovascular Diseases: a CALIBER Study
Impact of Cranioplasty On Cerebral Perfusion